XTANT MED HLDGS INC's ticker is XTNT and the CUSIP is 98420P308. A total of 28 filers reported holding XTANT MED HLDGS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,671,711 | -47.8% | 7,415,413 | -3.0% | 1.91% | -46.2% |
| Q1 2024 | $8,948,011 | -1.4% | 7,647,873 | -4.7% | 3.54% | -42.5% |
| Q4 2023 | $9,071,180 | -7.7% | 8,027,593 | -10.1% | 6.16% | +20.2% |
| Q3 2023 | $9,827,798 | +69.7% | 8,934,362 | +43.5% | 5.12% | +16.9% |
| Q2 2023 | $5,791,007 | +45.9% | 6,227,559 | 0.0% | 4.38% | +98.9% |
| Q1 2023 | $3,970,069 | -3.7% | 6,227,559 | -0.3% | 2.20% | +5.2% |
| Q4 2022 | $4,122,552 | -8.3% | 6,246,291 | 0.0% | 2.10% | +27.1% |
| Q3 2022 | $4,496,000 | +38.6% | 6,246,291 | 0.0% | 1.65% | +27.0% |
| Q2 2022 | $3,245,000 | -23.6% | 6,246,291 | 0.0% | 1.30% | -8.7% |
| Q1 2022 | $4,247,000 | +21.4% | 6,246,291 | 0.0% | 1.42% | +47.4% |
| Q4 2021 | $3,498,000 | -49.6% | 6,246,291 | -0.1% | 0.96% | -47.1% |
| Q3 2021 | $6,942,000 | -48.6% | 6,254,458 | -24.6% | 1.82% | -41.9% |
| Q2 2021 | $13,517,000 | – | 8,292,602 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 752,915 | $1,205,000 | 4.02% |
| Orbimed Advisors | 9,207,012 | $14,731,000 | 0.21% |
| Park West Asset Management LLC | 1,258,733 | $2,014,000 | 0.08% |
| Winslow, Evans & Crocker, Inc. | 1,258 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $80,000 | 0.00% |
| Rockefeller Capital Management L.P. | 120 | $0 | 0.00% |
| MBM Wealth Consultants, LLC | 33 | $0 | 0.00% |
| BlackRock Finance, Inc. | 10,309 | $16,000 | 0.00% |
| MORGAN STANLEY | 9,701 | $16,000 | 0.00% |
| Renaissance Technologies | 84,061 | $134,000 | 0.00% |